QuidelOrtho To Accelerate Growth In Molecular Diagnostics
QuidelOrtho is refocusing its molecular diagnostics strategy by discontinuing its Savanna platform and planning to acquire LEX Diagnostics.
Category: Molecular Diagnostics
Molecular Diagnostics
Latest
Molecular Diagnostics
Latest
WATCHFIRE PCR Test Detects Viruses and Bacteria in Wastewater
bioMérieux has launched the WATCHFIRE R Panel, a rapid wastewater-based molecular test that detects 22 respiratory pathogens.
Molecular Diagnostics
Latest
Simplexa C. Auris Direct Assay Launched by Diasorin
Diasorin has launched the Simplexa C. auris Direct kit to aid in identifying Candida auris and enhance infection control.
Galleri MCED Test Available via Quest’s Ordering System
GRAIL, Inc. and Quest Diagnostics have integrated the Galleri multi-cancer early detection (MCED) test into Quest’s connectivity system.
Read More
Biofidelity to Launch Enspyre Technology
Biofidelity is launching Enspyre, a novel target enrichment technology that significantly enhances NGS efficiency.
Read More
Novel LDTs Advance Dermatological Diagnostics
Molecular Instruments has introduced novel LDTs to improve the diagnosis and treatment of psoriasis and atopic dermatitis.
Read More
Multiplex Test for SARS-CoV-2, Flu A, Flu B, and RSV Receives 510(k) Clearance
Thermo Fisher Scientific has received FDA 510(k) clearance for its Applied Biosystems TaqPath COVID-19, Flu A, Flu B, RSV Select Panel, a real-time PCR multiplex test.
Read More
Metabolite Detection Method Using DNA Sequencing Invented
Researchers have developed a revolutionary method using DNA sequencing to rapidly and precisely measure metabolites critical for health.
Read More
Baylor Genetics Aims to Integrate with Epic Aura to Improve Access
Baylor Genetics has partnered with Epic’s Aura diagnostics suite, enabling ordering genetic tests and access results directly within the EHR.
Read More
Datar Cancer Genetics Unveils Advanced Blood Test for MRD
Datar Cancer Genetics introduced a blood test that combines tumor-agnostic NGS and tumor-informed dd-PCR to detect MRD.
Read More
FDA Grants Breakthrough Device Designation for CRISPR Blood Test for Tuberculosis
IntelliGenome’s CRISPR-TB Blood Test, designed to detect Mycobacterium tuberculosis cfDNA, received FDA Breakthrough Device Designation.
Read More
How Long-Read Sequencing Could Revolutionize Rare Genetic Disease Diagnosis
Researchers demonstrate the potential of long-read sequencing to diagnose rare genetic diseases faster and more accurately.
Read More
Blood Biomarkers Linked to SIDS Risk Identified
Researchers identified blood biomarkers associated with Sudden Infant Death Syndrome, paving the way for diagnostic tests for infants.
Read More
OGT Launches Myeloid MRD Panel for Sensitive AML Biomarker Detection
OGT’s SureSeq Myeloid MRD Panel offers a NGS solution for ultra-sensitive detection of MRD biomarkers in acute myeloid leukemia.
Read More
Bio-Rad Launches New ddPCR Kits for AAV Serotypes 2 and 8
Bio-Rad Labs expanded its Vericheck ddPCR Empty-Full Capsid Kit for precise measurement of capsid content to support gene therapies.
Read More
Avalon Healthcare Solutions and Sentara Health Plans Partner on Genetic Testing Management
Avalon Healthcare Solutions expanded its partnership with Sentara Health Plans for evidence-based genetic testing management services.
Read More
Using mcfDNA Testing for Pediatric Head and Neck Infection Diagnosis
Researchers demonstrated the potential of mcfDNA testing to identify pathogens in pediatric head and neck infections.
Read More
Scientists Discover Potential Blood Test for Asthma Diagnosis and Severity
Scientists identified a blood marker that can diagnose asthma and assess its severity, potentially transforming asthma diagnosis.
Read More